Dr Natalie Thorne is Melbourne Genomics' Lead of Innovation & Technology.

After a degree majoring in mathematics and statistics and minoring in genetics, Natalie completed her PhD at the Walter and Eliza Hall Institute's Bioinformatics division.

Natalie worked for Cancer Research UK at the Cambridge Research Institute in the computational biology group where she worked on a variety of microarray genomics applications in cancer and analysis of data from emerging genomic technologies. After five years in the UK, she returned to the Walter and Eliza Hall Institute in a senior postdoctoral position within the statistical genetics lab. Natalie's studies utilised high-throughput sequencing technology to discover disease-causing DNA mutations, focusing on projects to improve the use of whole genome sequencing for disease diagnosis.